NeuroSense Therapeutics Statistics
NASDAQ: NRSNHealthcareBiotechnologyUSD
3.58-0.24 (-6.28%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
NeuroSense Therapeutics by the numbers
NeuroSense Therapeutics has a market capitalization of $6.8 million based on 1.90M shares outstanding. With trailing EPS of $-47.10, NeuroSense Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 52.3% below its 50-day average and 74.5% below its 200-day average.
Average daily trading volume is 21.29K shares, or about $76,211 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NRSN valuation vs. peer median
| Metric | NRSN | Peer median | Difference |
|---|---|---|---|
| Market cap | $6.79M | $6.77M | +0% |
| Avg. volume | 21.29K | 113.96K | -81% |
Peer median across 8 companies: ENVB, LEXX, ACXP, APRE, BOLT, XCUR, CELZ, ALZN.
Valuation
- Market cap
- $6.79M
- EPS (TTM)
- $-47.10
- Shares outstanding
- 1.90M
Price and trading
- Previous close
- 3.82
- Open
- 3.82
- Day range
- 3.56 – 3.90
- 52-week range
- 3.56 – 26.64
- Beta
- —
- Volume
- 15.80K
- Average volume
- 21.29K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Jun 24, 2025
Additional statistics
- Market Cap
- 6.79M
- Forward Pe
- -0.30
- Eps
- -47.10
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 26.64
- Week52 Low
- 3.56
- Avg Volume
- 21,288.00
- Shares Outstanding
- 1.90M
- Ma50
- 7.51
- Ma200
- 14.06
- Earnings Date
- Jun 24, 2025
- Pct From52w High
- -86.56%
- Pct From52w Low
- 0.53%